HBK Sorce Advisory’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Buy |
11,602
+2,476
| +27% | +$90.3K | 0.01% | 372 |
|
|
2025
Q1 | $353K | Buy |
9,126
+932
| +11% | +$36K | 0.01% | 412 |
|
|
2024
Q4 | $311K | Buy |
8,194
+1,057
| +15% | +$40.1K | 0.01% | 441 |
|
|
2024
Q3 | $299K | Buy |
7,137
+100
| +1% | +$4.19K | 0.01% | 452 |
|
|
2024
Q2 | $287K | Buy |
7,037
+28
| +0.4% | +$1.14K | 0.01% | 452 |
|
|
2024
Q1 | $290K | Buy |
7,009
+884
| +14% | +$36.6K | 0.01% | 458 |
|
|
2023
Q4 | $248K | Buy |
6,125
+249
| +4% | +$10.1K | 0.01% | 454 |
|
|
2023
Q3 | $230K | Buy |
5,876
+386
| +7% | +$15.1K | 0.01% | 487 |
|
|
2023
Q2 | $223K | Sell |
5,490
-1,404
| -20% | -$57.1K | 0.01% | 514 |
|
|
2023
Q1 | $289K | Sell |
6,894
-5,810
| -46% | -$243K | 0.01% | 444 |
|
|
2022
Q4 | $554K | Buy |
12,704
+7,452
| +142% | +$325K | 0.01% | 392 |
|
|
2022
Q3 | $204K | Sell |
5,252
-1,030
| -16% | -$40K | 0.01% | 453 |
|
|
2022
Q2 | $266K | Buy |
6,282
+8
| +0.1% | +$339 | 0.02% | 366 |
|
|
2022
Q1 | $286K | Buy |
6,274
+315
| +5% | +$14.4K | 0.02% | 408 |
|
|
2021
Q4 | $289K | Hold |
5,959
| – | – | 0.01% | 453 |
|
|
2021
Q3 | $284K | Buy |
5,959
+200
| +3% | +$9.53K | 0.02% | 456 |
|
|
2021
Q2 | $279K | Buy |
+5,759
| New | +$279K | 0.02% | 468 |
|